Sort by
Refine Your Search
-
discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University
-
is ideal for someone with a background in some combination of behavior/learning theory approaches to anxiety, computational modeling of behavior, and fMRI analysis; and who wishes to gain or deepen
-
on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University programs and in the use of facilities without
-
preparation for analysis; and Contributing to the development and maintenance of a computable phenotype coding warehouse for the EPIC COSMOS database. This role offers an exciting opportunity to work at the
-
, immune-oncology or cell and cancer biology. Candidates with demonstrated expertise in cytometry and immunophenotyping, including sample processing, data acquisition, and data analysis using FlowJo/Cytobank
-
use of research techniques, including laboratory equipment, data analysis, and computerized methodologies. Calibrates, troubleshoots, and performs routine repair and maintenance of equipment and/or
-
contribute to the excellence of our academic community. The Division of Advancement and Alumni Engagement utilizes resources, technology, and business for the purpose of constituent engagement, donor research
-
. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff
-
expression, and veteran's status. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students
-
pediatric component of the Winship Cancer Institute of Emory University. The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease